Company / R&D per Share
Abbott Laboratories R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.68
FY2025
5-year range
$1.35 / $1.68
FY2021-FY2025
Trend
+4.3%
vs FY2024
Sector context
#55 of 108
Health Care
What the data says
At $1.68, Abbott Laboratories's r&d per share ranks #55 of 108 in the Health Care sector. R&D per Share has increased for 3 consecutive years, from $1.35 in FY2022 to $1.68 in FY2025.
Based on SEC 10-K filings.
1.68 in FY2025 with a 5-year CAGR of +5.3%.
Improved from $1.53 to $1.68 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +7.5%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Sector benchmark
#55 of 108 in Health CareTop 51% of 108This company $1.68 Sector average $2.07
▼
-18.9% below sector average
Key checks
Key Insights
- Abbott Laboratories's r&d per share has grown for 3 consecutive years.
- In FY2025, r&d per share increased 4.3% year-over-year.
- Ranks #55 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.68 | +4.3% |
| FY2024 | $1.61 | +5.2% |
| FY2023 | $1.53 | +13.1% |
| FY2022 | $1.35 | -1.1% |
| FY2021 | $1.37 | +5.4% |
| FY2020 | $1.30 | -6.9% |
| FY2019 | $1.40 | +43.0% |
| FY2018 | $0.98 | +4.6% |
| FY2017 | $0.93 | +5.9% |
| FY2016 | $0.88 | +1.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026